BNTX
BioNTech SE
97.60$
+0.8%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +0.0% | -6.0% | +212.7% | -59.0% | -1.4% | +11.2% | -2.4% | -1.0% | +50.5% | +61.9% | +411.8% | +493.0% | +159.2% | +14.7% | -9.1% | +15.2% | -49.9% | +8.3% | +23.6% | -70.2% | -86.9% | +433.9% | +65.2% | -87.3% | -31.4% | +867.2% | -4.4% | -84.6% | +42.7% | +482.4% | -40.8% | -86.6% | -12.0% | – | |
| – | +0.0% | -13.7% | +61.1% | -28.4% | +71.3% | -22.9% | +4.9% | +33.0% | -5.1% | +21.4% | +502.8% | +468.7% | +279.2% | +37.1% | -51.9% | +121.9% | -40.9% | -1.5% | -75.6% | -47.7% | +69.7% | -0.7% | +10.7% | -67.0% | +1.2% | +199.2% | +36.1% | -65.6% | -8.8% | +94.1% | +122.6% | -40.7% | -50.5% | – | |
| – | +0.0% | -4.7% | +236.6% | -61.3% | -11.6% | +20.4% | -3.6% | -7.4% | +65.6% | +68.1% | +401.6% | +496.2% | +143.7% | +10.2% | +1.5% | +2.7% | -52.1% | +11.4% | +51.2% | -71.2% | -99.6% | +15,181.3% | +77.2% | -90.1% | -46.4% | +1,447.0% | -11.2% | -89.5% | +86.3% | +643.3% | -58.5% | -113.3% | – | – | |
| – | +0.0% | +12.2% | +58.0% | +10.5% | -6.7% | -5.6% | +29.8% | -0.5% | +46.2% | +139.2% | +13.8% | -16.5% | -7.0% | +29.5% | +4.3% | +5.3% | +39.8% | -14.5% | +49.2% | -34.5% | +11.8% | +33.3% | +16.0% | -12.2% | +15.2% | -5.9% | +11.2% | -14.1% | -3.1% | +10.9% | -11.4% | +13.1% | -2.7% | – | |
| – | +0.0% | +35.7% | +19.4% | +6.1% | +57.3% | -19.0% | -41.3% | +154.4% | +8.9% | +29.7% | +29.9% | +34.3% | +22.9% | +42.7% | +87.7% | -29.1% | +39.5% | +7.7% | -4.2% | -14.5% | +7.2% | +16.1% | -5.5% | -11.0% | +46.1% | -22.5% | -16.3% | -3.5% | +10.1% | +3.0% | +100.0% | -49.3% | +28.3% | – | |
| – | +0.0% | +29.6% | +57.2% | +8.2% | +2.1% | -10.1% | +24.8% | +6.0% | +44.3% | +111.2% | -75.6% | +154.0% | +47.8% | -32.7% | +63.8% | +31.3% | -32.2% | +44.4% | +149.9% | -34.3% | +7.9% | +16.2% | +17.2% | -17.8% | +62.8% | +2.0% | -24.4% | -20.7% | +8.3% | +106.8% | -43.6% | -25.4% | +60.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | +580.7% | +152.6% | +12.5% | -0.5% | +1.1% | -53.5% | +8.1% | +37.9% | -80.1% | -186.1% | – | +619.8% | -196.4% | – | – | +1,315.2% | -459.4% | – | – | – | – | – | – | |
| – | – | – | -74.5% | +21.1% | +426.9% | -80.4% | -60.8% | +159.6% | +1,721.8% | +125.3% | +76.6% | +20.4% | +290.6% | -53.0% | -97.5% | +220.7% | -13.1% | -24.9% | -52.6% | -43.6% | +9.6% | +59.1% | +818.8% | -75.0% | +54.3% | -28.8% | +42.0% | -15.9% | -47.1% | -87.9% | +1,513.5% | -36.9% | +94.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | +698.7% | +144.9% | +16.0% | +1.0% | +6.5% | -53.8% | +5.4% | +29.8% | -77.7% | -158.2% | – | +191.6% | -150.0% | – | – | +89.8% | -247.9% | – | – | -1,012.0% | – | – | – | |
| – | +0.0% | +11,360.0% | -97.0% | -64.7% | +116.7% | -38.5% | -3,800.0% | – | -27,600.0% | – | -6,551.7% | – | +140.3% | +17.9% | +6.3% | -14.8% | -50.9% | +1.8% | +35.6% | -77.0% | -207.9% | – | +207.3% | -108.1% | – | -2,070.0% | – | -171.0% | – | – | +44.0% | -147.9% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | +207.5% | +147.1% | +15.2% | -1.4% | +16.8% | -54.8% | +6.8% | +27.7% | -78.0% | -137.9% | – | +185.1% | -168.8% | – | – | +31.0% | -260.2% | – | – | – | – | – | – | |
| – | – | – | – | -560.5% | – | – | – | – | – | – | – | +752.4% | +143.9% | +16.0% | +1.2% | +6.5% | -53.3% | +5.2% | +29.1% | -76.0% | -149.3% | – | +68.3% | -163.4% | – | – | +120.0% | -179.4% | – | – | -137.2% | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.